Peter Amanatides has become vice president of quality assurance and quality control for Noven Pharmaceuticals. Prior to Noven, he held several senior positions at DSM Pharmaceuticals. Before that, he was director of quality systems at Celera Genomics. Amanatides holds an MS in biotechnology and molecular biology from Hood College and a BS in biology from Regents College.
Elias Zerhouni, John Leamon, Peter Amanatides
Sep 30, 2008
National Institutes of Health Director Elias Zerhouni will resign from his position at the end of October "to pursue writing projects and explore other professional opportunities." Raynard Kington, deputy director of NIH, will likely serve as acting director until a new administration names his successor. Zerhouni was appointed to the directorship of NIH in 2002 by President George W. Bush.
John Leamon has become director of molecular biology at Ion Torrent Systems in Guilford, Conn. He joined the company from RainDance Technologies, where he was a project leader.